Sleep neurobiology for the clinician

Sleep

Volumn 27, Issue 4, 2004, Pages 811-820

  España, Rodrigo A ^a   Scammell, Thomas E ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Arousal; Hypocretin; Neurotransmitter; Orexin; VLPO; Waking

Indexed keywords

ACETYLCHOLINE; DOPAMINE; HISTAMINE; NORADRENALIN; OREXIN; SEROTONIN;

ALERTNESS; AROUSAL; BEHAVIOR; BRAIN DEPTH STIMULATION; BRAIN FUNCTION; BRAIN NERVE CELL; BRAIN REGION; BRAIN STEM; CATECHOLAMINE SYNTHESIS; HUMAN; HYPOTHALAMUS; NERVE CONDUCTION; NERVE PROJECTION; NEUROBIOLOGY; NEUROTRANSMITTER RELEASE; NONREM SLEEP; PONS; PREOPTIC AREA; PRIORITY JOURNAL; REGULATORY MECHANISM; REM SLEEP; REVIEW; SLEEP; SLEEP WAKING CYCLE; WAKEFULNESS;

ACETYLCHOLINE; BRAIN STEM; CARRIER PROTEINS; DOPAMINE; HISTAMINE; HUMANS; HYPOTHALAMUS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEURONS; NEUROPEPTIDES; NOREPINEPHRINE; SEROTONIN; SLEEP, REM; WAKEFULNESS;

EID: 3042621975     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (175)

1. Von Economo C. Sleep as a problem of localization. J Nerv Ment Dis 1930; 71:249-259.
2. Moruzzi G, Magoun HW. Brain stem reticular formation and activation of the EEG. Electroencephalogr Clin Neurophysiol 1949; 1:455-473.
3. Jones B. Reticular formation. Cytoarchitecture, transmitters and projections. The Rat Nervous System. New South Wales: Academic Press Australia, 1995: 155-171.
4. Jones BE, Yang TZ. The efferent projections from the reticular formation and the locus coeruleus studied by anterograde and retrograde axonal transport in the rat. J Comp Neurol 1985; 242:56-92.
5. Steriade M, Oakson G, Ropert N. Firing rates and patterns of mid-brain reticular neurons during steady and transitional states of the sleep-waking cycle. Exp Brain Res 1982; 46:37-51.
6. Jones BE. Arousal systems. Front Biosci 2003; 8:s438-s451.
7. Armstrong DM, Saper CB, Levey Al, Wainer BH, Terry RD. Distribution of cholinergic neurons in rat brain: demonstrated by the immunocytochemical localization of choline acetyltransferase. J Comp Neurol 1983; 216:53-68.
8. Woolf NJ. Cholinergic systems in mammalian brain and spinal cord. Prog Neurobiol 1991; 37:475-524.
9. Mesulam MM, Mufson EJ, Wainer BH, Levey Al. Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6). Neuroscience 1983; 10:1185-1201.
10. Steriade M, Pare D, Parent A, Smith Y. Projections of cholinergic and non-cholinergic neurons of the brainstem core to relay and associational thalamic nuclei in the cat and macaque monkey. Neuroscience 1988; 25:47-67.
11. Jones BE, Cuello AC. Afferents to the basal forebrain cholinergic cell area from pontomesencephalic-catecholamine, serotonin, and acetylcholine- neurons. Neuroscience 1989; 31:37-61.
12. Jasper HH, Tessier J. Acetylcholine liberation from cerebral cortex during paradoxical (REM) sleep. Science 1971; 172:601-602.
13. Detari L, Vanderwolf CH. Activity of identified cortically projecting and other basal forebrain neurones during large slow waves and cortical activation in anaesthetized rats. Brain Res 1987; 437:1-8.
14. Steriade M, Datta S, Pare D, Oakson G, Curro Dossi RC. Neuronal activities in brain-stem cholinergic nuclei related to tonic activation processes in thalamocortical systems. J Neurosci 1990; 10:2541-2559.
15. Williams JA, Comisarow J, Day J, Fibiger HC, Reiner PB. State-dependent release of acetylcholine in rat thalamus measured by in vivo microdialysis. J Neurosci 1994; 14:5236-5242.
16. Lee MG, Henny P, Jones B. Sleep-wake discharge properties of juxtacellularly labeled and immunohistochemically identified cholinergic basal forebrain neurons in head-restrained rats. Society for Neuroscience Meeting; 2003 November 8-12; New Orleans, LA; abstract 932.26.
17. Marrosu F, Portas C, Mascia MS et al. Microdialysis measurement of cortical and hippocampal acetylcholine release during sleep-wake cycle in freely moving cats. Brain Res 1995; 671:329-332.
18. Yamamoto KI, Domino EF. Cholinergic agonist-antagonist interactions on neocortical and limbic EEG activation. Int J Neuropharmacol 1967; 6:357-373.
19. Domino EF, Yamamoto K, Dren AT. Role of cholinergic mechanisms in states of wakefulness and sleep. Prog Brain Res 1968; 28:113-133.
20. Gillin JC, Sutton L, Ruiz C et al. The effects of scopolamine on sleep and mood in depressed patients with a history of alcoholism and a normal comparison group. Biol Psychiatry 1991; 30:157-169.
21. Metherate R, Cox CL, Ashe JH. Cellular bases of neocortical activation: modulation of neural oscillations by the nucleus basalis and endogenous acetylcholine. J Neurosci 1992; 12:4701-4711.
22. Davila DG, Hurt RD, Offord KP, Harris CD, Shepard JW, Jr. Acute effects of transdermal nicotine on sleep architecture, snoring, and sleep-disordered breathing in nonsmokers. Am J Respir Crit Care Med 1994; 150:469-474.
23. Buzsaki G, Bickford RG, Ponomareff G, Thal LJ, Mandel R, Gage FH. Nucleus basalis and thalamic control of neocortical activity in the freely moving rat. J Neurosci 1988; 8:4007-4026.
24. Stewart DJ, MacFabe DF, Vanderwolf CH. Cholinergic activation of the electrocorticogram: role of the substantia innominata and effects of atropine and quinuclidinyl benzilate. Brain Res 1984; 322:219-232.
25. Pickworth WB, Herning RI, Koeppl B, Henningfield JE. Dose-dependent atropine-induced changes in spontaneous electroencephalogram in human volunteers. Mil Med 1990; 155:166-170.
26. Ray PG, Jackson WJ. Lesions of nucleus basalis alter ChAT activity and EEG in rat frontal neocortex. Electroencephalogr Clin Neurophysiol 1991; 79:62-68.
27. Prinz PN, Peskind ER, Vitaliano PP et al. Changes in the sleep and waking EEGs of nondemented and demented elderly subjects. J Am Geriatr Soc 1982; 30:86-93.
28. Morrison JH, Foote SL. Noradrenergic and serotoninergic innervation of cortical, thalamic, and tectal visual structures in Old and New World monkeys. J Comp Neurol 1986; 243:117-138.
29. Lewis DA, Campbell MJ, Foote SL, Goldstein M, Morrison JH. The distribution of tyrosine hydroxylase-immunoreactive fibers in primate neocortex is widespread but regionally specific. J Neurosci 1987; 7:279-290.
30. Hobson JA, McCarley RW, Wyzinski PW. Sleep cycle oscillation: reciprocal discharge by two brainstem neuronal groups. Science 1975; 189:55-58.
31. Foote SL, Aston-Jones G, Bloom FE. Impulse activity of locus coeruleus neurons in awake rats and monkeys is a function of sensory stimulation and arousal. Proc Natl Acad Sci 1980; 77:3033-3037.
32. Aston-Jones G, Bloom FE. Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J Neurosci 1981; 1:876-886.
33. Berridge CW, Foote SL. Effects of locus coeruleus activation on electroencephalographic activity in neocortex and hippocampus. J Neurosci 1991; 11:3135-3145.
34. Florin-Lechner SM, Druhan JP, Aston-Jones G, Valentino RJ. Enhanced norepinephrine release in prefrontal cortex with burst stimulation of the locus coeruleus. Brain Res 1996; 742:89-97.
35. Berridge CW, Abercrombie ED. Relationship between locus coeruleus discharge rates and rates of norepinephrine release within neocortex as assessed by in vivo microdialysis. Neuroscience 1999; 93:1263-1270.
36. De Sarro GB, Ascioti C, Froio F, Libri V, Nistico G. Evidence that locus coeruleus is the site where clonidine and drugs acting at alpha 1- and alpha 2-adrenoceptors affect sleep and arousal mechanisms. Br J Pharmacol 1987; 90:675-685.
37. Berridge CW, Page ME, Valentino RJ, Foote SL. Effects of locus coeruleus inactivation on electroencephalographic activity in neocortex and hippocampus. Neuroscience 1993; 55:381-393.
38. Berridge CW, España RA. Synergistic sedative effects of noradrenergic alpha(1)- and beta- receptor blockade on forebrain electroencephalographic and behavioral indices. Neuroscience 2000; 99:495-505.
39. Hunsley MS, Palmiter RD. Norepinephrine-deficient mice exhibit normal sleep-wake states but have shorter sleep latency after mild stress and low doses of amphetamine. Sleep 2003; 26:521-526.
40. Panula P, Pirvola U, Auvinen S, Airaksinen MS. Histamine-immunoreactive nerve fibers in the rat brain. Neuroscience 1989; 28:585-610.
41. Inagaki N, Yamatodani A, Ando-Yamamoto M, Tohyama M, Watanabe T, Wada H. Organization of histaminergic fibers in the rat brain. J Comp Neurol 1988; 273:283-300.
42. Steininger TL, Alam MN, Gong H, Szymusiak R, McGinty D. Sleep-waking discharge of neurons in the posterior lateral hypothalamus of the albino rat. Brain Res 1999; 840:138-147.
43. Ko EM, Estabrooke IV, McCarthy M, Scammell TE. Wake-related activity of tuberomammillary neurons in rats. Brain Res 2003; 992:220-226.
44. Lin JS, Sakai K, Jouvet M. Evidence for histaminergic arousal mechanisms in the hypothalamus of cat. Neuropharmacology 1988; 27:111-122.
45. Monti JM, Pellejero T, Jantos H. Effects of H1- and H2-histamine receptor agonists and antagonists on sleep and wakefulness in the rat. J Neural Transm 1986; 66:1-11.
46. Mochizuki T, Yamatodani A, Okakura K, Horii A, Inagaki N, Wada H. Circadian rhythm of histamine release from the hypothalamus of freely moving rats. Physiol Behav 1992; 51:391-394.
47. Roehrs TA, Tietz El, Zorick FJ, Roth T. Daytime sleepiness and antihistamines. Sleep 1984; 7:137-141.
48. Tasaka K, Chung YH, Sawada K, Mio M. Excitatory effect of histamine on the arousal system and its inhibition by H1 blockers. Brain Res Bull 1989; 22:271-275.
49. Monti JM, Jantos H, Ponzoni A, Monti D. Sleep and waking during acute histamine H3 agonist BP 2.94 or H3 antagonist carboperamide (MR 16155) administration in rats. Neuropsychopharmacology 1996; 15:31-35.
50. Parmentier R, Ohtsu H, Djebbara-Hannas Z, Valatx JL, Watanabe T, Lin JS. Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep-wake control. J Neurosci 2002; 22:7695-7711.
51. Azmitia EC, Segal M. An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J Comp Neurol 1978; 179:641-667.
52. Törk I. Anatomy of the serotonergic system. Ann N Y Acad Sci 1990; 600:9-34.
53. Trulson ME, Jacobs BL. Raphe unit activity in freely moving cats: correlation with level of behavioral arousal. Brain Res 1979; 163:135-150.
54. Puizillout JJ, Gaudin-Chazal G, Daszuta A, Seyfritz N, Ternaux JP. Release of endogenous serotonin from "encephale isole" cats. II - Correlations with raphe neuronal activity and sleep and wakefulness. J Physiol 1979; 75:531-537.
55. Portas CM, Bjorvatn B, Fagerland S et al. On-line detection of extracellular levels of serotonin in dorsal raphe nucleus and frontal cortex over the sleep/wake cycle in the freely moving rat. Neuroscience 1998; 83:807-814.
56. Hoyer D, Martin G. 5-HT receptor classification and nomenclature: towards a harmonization with the human genome. Neuropharmacology 1997; 36:419-428.
57. Jouvet M. The role of monoamines and acetylcholine-containing neurons in the regulation of the sleep-waking cycle. Ergeb Physiol 1972; 64:166-307.
58. Koella WP. Serotonin and sleep. Exp Med Surg 1969; 27:157-168.
59. Koe BK, Weissman A. p-Chlorophenylalanine: a specific depletor of brain serotonin. J Pharmacol Exp Ther 1966; 154:499-516.
60. Monti JM, Jantos H. Dose-dependent effects of the 5-HT1A receptor agonist 8-OH-DPAT on sleep and wakefulness in the rat. J Sleep Res 1992; 1:169-175.
61. Bjorvatn B, Fagerland S, Eid T, Ursin R. Sleep/waking effects of a selective 5-HT1A receptor agonist given systemically as well as perfused in the dorsal raphe nucleus in rats. Brain Res 1997; 770:81-88.
62. Ursin R. The effects of 5-hydroxytryptophan and L-tryptophan on wakefulness and sleep patterns in the cat. Brain Res 1976; 106:105-115.
63. Wojcik WJ, Fornal C, Radulovacki M. Effect of tryptophan on sleep in the rat. Neuropharmacology 1980; 19:163-167.
64. Bjorvatn B, Ursin R. Effects of zimeldine, a selective 5-HT reuptake inhibitor, combined with ritanserin, a selective 5-HT2 antagonist, on waking and sleep stages in rats. Behav Brain Res 1990; 40:239-246.
65. Dzoljic MR, Ukponmwan OE, Saxena PR. 5-HT1-like receptor agonists enhance wakefulness. Neuropharmacology 1992; 31:623-633.
66. Driver HS, Flanigan MJ, Bentley AJ, Luus HG, Shapiro CM, Mitchell D. The influence of ipsapirone, a 5-HT1A agonist, on sleep patterns of healthy subjects. Psychopharmacology 1995; 117:186-192.
67. Boutrel B, Monaca C, Hen R, Hamon M, Adrien J. Involvement of 5-HT1A receptors in homeostatic and stress-induced adaptive regulations of paradoxical sleep: studies in 5-HT1A knock-out mice. J Neurosci 2002; 22:4686-4692.
68. Dugovic C, Wauquier A, Leysen JE, Marrannes R, Janssen PA. Functional role of 5-HT2 receptors in the regulation of sleep and wakefulness in the rat. Psychopharmacology 1989; 97:436-442.
69. Bjorvatn B, Ursin R. Effects of the selective 5-HT1B agonist, CGS 12066B, on sleep/waking stages and EEG power spectrum in rats. J Sleep Res 1994; 3:97-105.
70. Boutrel B, Franc B, Hen R, Hamon M, Adrien J. Key role of 5-HT1B receptors in the regulation of paradoxical sleep as evidenced in 5-HT1B knock-out mice. J Neurosci 1999; 19:3204-3212.
71. Ponzoni A, Monti JM, Jantos H. The effects of selective activation of the 5-HT3 receptor with m-chlorophenylbiguanide on sleep and wakefulness in the rat. Eur J Pharmacol 1993; 249:259-264.
72. McGrath PJ, Stewart JW, Janal MN, Petkova E, Quitkin FM, Klein DF. A placebo-controlled study of fluoxetine versus imipramine in the acute treatment of atypical depression. Am J Psychiatry 2000; 157:344-350.
73. Hillarp NA, Fuxe K, Dahlstrom A. Demonstration and mapping of central neurons containing dopamine, noradrenaline, and 5-hydroxytryptamine and their reactions to psychopharmaca. Pharmacol Rev 1966; 18:727-741.
74. Freeman A, Ciliax B, Bakay R et al. Nigrostriatal collaterals to thalamus degenerate in parkinsonian animal models. Ann Neurol 2001; 50:321-329.
75. Trulson ME, Preussler DW, Howell GA. Activity of substantia nigra units across the sleep-waking cycle in freely moving cats. Neurosci Lett 1981; 26:183-188.
76. Steinfels GF, Heym J, Strecker RE, Jacobs BL. Behavioral correlates of dopaminergic unit activity in freely moving cats. Brain Res 1983; 258:217-228.
77. Trulson ME, Preussler DW. Dopamine-containing ventral tegmental area neurons in freely moving cats: activity during the sleep-waking cycle and effects of stress. Exp Neurol 1984; 83:367-377.
78. Trulson ME. Simultaneous recording of substantia nigra neurons and voltammetric release of dopamine in the caudate of behaving cats. Brain Res Bull 1985; 15:221-223.
79. Feenstra MG, Botterblom MH, Mastenbroek S. Dopamine and noradrenaline efflux in the prefrontal cortex in the light and dark period: effects of novelty and handling and comparison to the nucleus accumbens. Neuroscience 2000; 100:741-748.
80. Monti JM, Fernandez M, Jantos H. Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonist SCH 23390 administration in rats. Neuropsychopharmacology 1990; 3:153-162.
81. Trampus M, Ferri N, Monopoli A, Ongini E. The dopamine D1 receptor is involved in the regulation of REM sleep in the rat. Eur J Pharmacol 1991; 194:189-194.
82. Trampus M, Ferri N, Adami M, Ongini E. The dopamine D1 receptor agonists, A68930 and SKF 38393, induce arousal and suppress REM sleep in the rat. Eur J Pharmacol 1993; 235:83-87.
83. Isaac SO, Berridge CW. Wake-promoting actions of dopamine D1 and D2 receptor stimulation. J Pharmacol Exp Ther 2003; 307:386-394.
84. Lu J, Chou TC, Saper CB. Identification of wake-active neurons inthe ventral periaqueductal gray (PAG). Society for Neuroscience Meeting; 2002 November 2-7; Orlando, FL; abstract 871.8.
85. Wisor JP, Nishino S, Sora I, Uhl GH, Mignot E, Edgar DM. Dopaminergic role in stimulant-induced wakefulness. J Neurosci 2001; 21:1787-1794.
86. Branchey MH, Brebbia DR, Cooper TB, Simpson GM. Effects of loxapine on the sleep of chronic schizophrenics. Psychopharmacology 1979; 62:201-206.
87. Neylan TC, van Kammen DP, Kelley ME, Peters JL. Sleep in schizophrenic patients on and off haloperidol therapy. Clinically stable vs relapsed patients. Arch Gen Psychiatry 1992; 49:643-649.
88. Ongini E, Bonizzoni E, Ferri N, Milani S, Trampus M. Differential effects of dopamine D-1 and D-2 receptor antagonist antipsychotics on sleep-wake patterns in the rat. J Pharmacol Exp Ther 1993; 266:726-731.
89. Roth T, Rye DB, Borchert LD et al. Assessment of sleepiness and unintended sleep in Parkinson's disease patients taking dopamine agonists. Sleep Med 2003; 4:275-280.
90. Brodsky MA, Godbold J, Roth T, Olanow CW. Sleepiness in Parkinson's disease: a controlled study. Mov Disord 2003; 18:668-72.
91. Paus S, Brecht HM, Koster J, Seeger G, Klockgether T, Wullner U. Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease. Mov Disord 2003; 18:659-667.
92. Monti JM, Jantos H, Fernandez M. Effects of the selective dopamine D-2 receptor agonist, quinpirole on sleep and wakefulness in the rat. Eur J Pharmacol 1989; 169:61-66.
93. Python A, de Saint HZ, Gaillard JM. Effects of a D2 receptor agonist RO 41-9067 alone and with clonidine on sleep parameters in the rat. Pharmacol Biochem Behav 1996; 53:291-296.
94. Lagos P, Scorza C, Monti JM et al. Effects of the D3 preferring dopamine agonist pramipexole on sleep and waking, locomotor activity and striatal dopamine release in rats. Eur Neuropsychopharmacol 1998; 8:113-120.
95. Sakurai T, Amemiya A, Ishii M et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998; 92:1.
96. de Lecea L, Kilduff TS, Peyron C et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci 1998; 95:322-327.
97. Peyron C, Tighe DK, van Den Pol AN et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998; 18:9996-10015.
98. Chemelli RM, Willie JT, Sinton CM et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999; 98:437-451.
99. Date Y, Ueta Y, Yamashita H et al. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc Natl Acad Sci 1999; 96:748-753.
100. Taheri S, Mahmoodi M, Opacka-Juffry J, Ghatei MA, Bloom SR. Distribution and quantification of immunoreactive orexin A in rat tissues. FEBS Lett 1999; 457:157-161.
101. Nambu T, Sakurai T, Mizukami K, Hosoya Y, Yanagisawa M, Goto K. Distribution of orexin neurons in the adult rat brain. Brain Res 1999; 827:243-260.
102. Estabrooke IV, McCarthy MT, Ko E et al. Fos expression in orexin neurons varies with behavioral state. J Neurosci 2001; 21:1656-1662.
103. España RA, Valentino RJ, Berridge CW. Fos immunoreactivity in hypocretin-synthesizing and hypocretin-1 receptor-expressing neurons: effects of diurnal and nocturnal spontaneous waking, stress and hypocretin-1 administration. Neuroscience 2003; 121:201-217.
104. Zeitzer JM, Buckmaster CL, Parker KJ, Hauck CM, Lyons DM, Mignot E. Circadian and homeostatic regulation of hypocretin in a primate model: implications for the consolidation of wakefulness. J Neurosci 2003; 23:3555-3560.
105. Kiyashchenko LI, Mileykovskiy BY, Maidment N et al. Release of hypocretin (orexin) during waking and sleep states. J Neurosci 2002; 22:5282-5286.
106. Hagan JJ, Leslie RA, Patel S et al. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci 1999; 96:10911-10916.
107. Bourgin P, Huitron-Resendiz S, Spier AD et al. Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons. J Neurosci 2000; 20:7760-7765.
108. Methippara MM, Alam MN, Szymusiak R, McGinty D. Effects of lateral preoptic area application of orexin-A on sleep-wakefulness. Neuroreport 2000; 11:3423-3426.
109. Piper DC, Upton N, Smith MI, Hunter AJ. The novel brain neuropeptide, orexin-A, modulates the sleep-wake cycle of rats. Eur J Neurosci 2000; 12:726-730.
110. España RA, Baldo BA, Kelley AE, Berridge CW. Wake-promoting and sleep-suppressing actions of hypocretin (orexin): basal forebrain sites of action. Neuroscience 2001; 106:699-715.
111. Thakkar MM, Ramesh V, Strecker RE, McCarley RW. Microdialysis perfusion of orexin-A in the basal forebrain increases wakefulness in freely behaving rats. Arch Ital Biol 2001; 139:313-328.
112. Mignot E, Lammers GJ, Ripley B et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 2002; 59:1553-1562.
113. Peyron C, Faraco J, Rogers W et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000; 6:991-997.
114. Thannickal TC, Moore RY, Nienhuis R et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000; 27:469-474.
115. Lin L, Faraco J, Li R et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999; 98:365-376.
116. Kisanuki YY, Chemelli RM, Sinton CM, Williams S.C., Richardson JA. The role of orexin receptor type-1 (OXIR) in the regulation of sleep. Sleep 23, A91. 2000.
117. Li Y, Gao XB, Sakurai T, van Den Pol AN. Hypocretin/Orexin excites hypocretin neurons via a local glutamate neuron-A potential mechanism for orchestrating the hypothalamic arousal system. Neuron 2002; 36:1169-1181.
118. Yamanaka A, Muraki Y, Tsujino N, Goto K, Sakurai T. Regulation of orexin neurons by the monoaminergic and cholinergic systems. Biochem Biophys Res Commun 2003; 303:120-129.
119. Mitome M, Honma S, Yoshihara T, Honma K. Prefeeding increase in paraventricular NE release is regulated by a feeding-associated rhythm in rats. Am J Physiol 1994; 266:E606-E611.
120. Yamanaka A, Beuckmann CT, Willie JT et al. Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron 2003; 38:701-713.
121. Pickel VM, Joh TH, Reis DJ. A serotonergic innervation of noradrenergic neurons in nucleus locus coeruleus: demonstration by immunocytochemical localization of the transmitter specific enzymes tyrosine and tryptophan hydroxylase. Brain Res 1977; 131:197-214.
122. Svensson TH, Engberg G. Effect of nicotine on single cell activity in the noradrenergic nucleus locus coeruleus. Acta Physiol Scand Suppl 1980; 479:31-34.
123. Wamsley JK, Lewis MS, Young WS, III, Kuhar MJ. Autoradiographic localization of muscarinic cholinergic receptors in rat brainstem. J Neurosci 1981; 1:176-191.
124. Baghdoyan HA, Mallios VJ, Duckrow RB, Mash DC. Localization of muscarinic receptor subtypes in brain stem areas regulating sleep. Neuroreport 1994; 5:1631-1634.
125. Lin JS, Hou Y, Sakai K, Jouvet M. Histaminergic descending inputs to the mesopontine tegmentum and their role in the control of cortical activation and wakefulness in the cat. J Neurosci 1996; 16:1523-1537.
126. Brown RE, Sergeeva O, Eriksson KS, Haas HL. Orexin A excites serotonergic neurons in the dorsal raphe nucleus of the rat. Neuropharmacology 2001; 40:457-459.
127. Eriksson KS, Sergeeva O, Brown RE, Haas HL. Orexin/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus. J Neurosci 2001; 21:9273-9279.
128. Burlet S, Tyler CJ, Leonard CS. Direct and indirect excitation of laterodorsal tegmental neurons by hypocretin/orexin peptides: implications for wakefulness and narcolepsy. J Neurosci 2002; 22:2862-2872.
129. Korotkova TM, Sergeeva OA, Eriksson KS, Haas HL, Brown RE. Excitation of ventral tegmental area dopaminergic and non-dopaminergic neurons by orexins/hypocretins. J Neurosci 2003; 23:7-11.
130. Kaitin KI. Preoptic area unit activity during sleep and wakefulness in the cat. Exp Neurol 1984; 83:347-357.
131. Burikov AA, Suntsova NV. The neuronal impulse activity of the preoptic area in the rabbit during electrocorticographic correlates of wakefulness and slow-wave sleep. Zh Vyssh Nerv Deiat Im I P Pavlova 1989; 39:1146-1148.
132. Koyama Y, Hayaishi O. Firing of neurons in the preoptic/anterior hypothalamic areas in rat: its possible involvement in slow wave sleep and paradoxical sleep. Neurosci Res 1994; 19:31-38.
133. Alam MN, McGinty D, Szymusiak R. Neuronal discharge of preoptic/anterior hypothalamic thermosensitive neurons: relation to NREM sleep. Am J Physiol 1995; 269:R1240-R1249.
134. Suntsova NV, Burikov AA. The restructuring of the neuronal activity of the lateral hypothalamic preoptic area during the development of sleep. Zh Vyssh Nerv Deiat Im I P Pavlova 1995; 45:948-956.
135. Gong H, Szymusiak R, King J, Steininger T, McGinty D. Sleep-related c-Fos protein expression in the preoptic hypothalamus: effects of ambient warming. Am J Physiol Regul Integr Comp Physiol 2000; 279:R2079-R2088.
136. Szymusiak R, Alam N, Steininger TL, McGinty D. Sleep-waking discharge patterns of ventrolateral preoptic/anterior hypothalamic neurons in rats. Brain Res 1998; 803:178-188.
137. Sherin JE, Elmquist JK, Torrealba F, Saper CB. Innervation of histaminergic tuberomammillary neurons by GABAergic and galaninergic neurons in the ventrolateral preoptic nucleus of the rat. J Neurosci 1998; 18:4705-4721.
138. Steininger TL, Gong H, McGinty D, Szymusiak R. Subregional organization of preoptic area/anterior hypothalamic projections to arousal-related monoaminergic cell groups. J Comp Neurol 2001; 429:638-653.
139. Gaus SE, Strecker RE, Tate BA, Parker RA, Saper CB. Ventrolateral preoptic nucleus contains sleep-active, galaninergic neurons in multiple mammalian species. Neuroscience 2002; 115:285-294.
140. Ericson H, Blomqvist A, Kohler C. Origin of neuronal inputs to the region of the tuberomammillary nucleus of the rat brain. J Comp Neurol 1991; 311:45-64.
141. Yoshimoto Y, Sakai K, Luppi PH, Fort P, Salvert D, Jouvet M. Forebrain afferents to the cat posterior hypothalamus: a double labeling study. Brain Res Bull 1989; 23:83-104.
142. Lu J, Greco MA, Shiromani P, Saper CB. Effect of lesions of the ventrolateral preoptic nucleus on NREM and REM sleep. J Neurosci 2000; 20:3830-3842.
143. Sallanon M, Denoyer M, Kitahama K, Aubert C, Gay N, Jouvet M. Long-lasting insomnia induced by preoptic neuron lesions and its transient reversal by muscimol injection into the posterior hypothalamus in the cat. Neuroscience 1989; 32:669-683.
144. el Mansari M, Sakai K, Jouvet M. Unitary characteristics of presumptive cholinergic tegmental neurons during the sleep-waking cycle in freely moving cats. Exp Brain Res 1989; 76:519-529.
145. Boissard R, Gervasoni D, Schmidt MH, Barbagli B, Fort P, Luppi PH. The rat ponto-medullary network responsible for paradoxical sleep onset and maintenance: a combined microinjection and functional neuroanatomical study. Eur J Neurosci 2002; 16:1959-1973.
146. Webster HH, Jones BE. Neurotoxic lesions of the dorsolateral pontomesencephalic tegmentum-cholinergic cell area in the cat. II. Effects upon sleep-waking states. Brain Res 1988; 458:285-302.
147. Shouse MN, Siegel JM. Pontine regulation of REM sleep components in cats: integrity of the pedunculopontine tegmentum (PPT) is important for phasic events but unnecessary for atonia during REM sleep. Brain Res 1992; 571:50-63.
148. Holmes CJ, Jones BE. Importance of cholinergic, GABAergic, serotonergic and other neurons in the medial medullary reticular formation for sleep-wake states studied by cytotoxic lesions in the cat. Neuroscience 1994; 62:1179-1200.
149. Velazquez-Moctezuma J, Gillin JC, Shiromani PJ. Effect of specific M1, M2 muscarinic receptor agonists on REM sleep generation. Brain Res 1989; 503:128-131.
150. Nitz D, Siegel J. GABA release in the dorsal raphe nucleus: role in the control of REM sleep. Am J Physiol 1997; 273:R451-R455.
151. Gervasoni D, Darracq L, Fort P, Souliere F, Chouvet G, Luppi PH. Electrophysiological evidence that noradrenergic neurons of the rat locus coeruleus are tonically inhibited by GABA during sleep. Eur J Neurosci 1998; 10:964-970.
152. Crochet S, Sakai K. Effects of microdialysis application of monoamines on the EEG and behavioural states in the cat mesopontine tegmentum. Eur J Neurosci 1999; 11:3738-3752.
153. Morales FR, Engelhardt JK, Soja PJ, Pereda AE, Chase MH. Motoneuron properties during motor inhibition produced by microinjection of carbachol into the pontine reticular formation of the decerebrate cat. J Neurophysiol 1987; 57:1118-1129.
154. Curtis DR, Hosli L, Johnston GA, Johnston IH. The hyperpolarization of spinal motoneurones by glycine and related amino acids. Exp Brain Res 1968; 5:235-258.
155. Mileykovskiy BY, Kiyashchenko LI, Siegel JM. Cessation of activity in red nucleus neurons during stimulation of the medial medulla in decerebrate rats. J Physiol 2002; 545:997-1006.
156. Morrison JL, Sood S, Liu H et al. Role of inhibitory amino acids in control of hypoglossal motor outflow to genioglossus muscle in naturally sleeping rats. J Physiol 2003; 552:975-991.
157. Kubin L, Tojima H, Davies RO, Pack AI. Serotonergic excitatory drive to hypoglossal motoneurons in the decerebrate cat. Neurosci Lett 1992; 139:243-248.
158. Legendre R, Piéron H. Recherches sur le besoin de sommeil consecutif à une veille prolongée. Z Allgem Physiol 1913; 14:235-262.
159. Ishimori K. True cause of sleep: A hypnogenic substance as evidenced in the brain of sleep-deprived animals. Tokyo Igakkai Zasshi 1909; 23:429-457.
160. Obal F, Jr., Krueger JM. Biochemical regulation of non-rapid-eye-movement sleep. Front Biosci 2003; 8:d520-d550.
161. Porkka-Heiskanen T, Strecker RE, Thakkar M, Bjorkum AA, Greene RW, McCarley RW. Adenosine: a mediator of the sleep-inducing effects of prolonged wakefulness. Science 1997; 276:1265-1268.
162. Thakkar MM, Delgiacco RA, Strecker RE, McCarley RW. Adenosinergic inhibition of basal forebrain wakefulness-active neurons: a simultaneous unit recording and microdialysis study in freely behaving cats. Neuroscience 2003; 122:1107-1113.
163. Chamberlin NL, Arrigoni E, Chou TC, Scammell TE, Greene RW, Saper CB. Effects of adenosine on gabaergic synaptic inputs to identified ventrolateral preoptic neurons. Neuroscience 2003; 119:913-918.
164. Stenberg D, Litonius E, Halldner L, Johansson B, Fredholm BB, Porkka-Heiskanen T. Sleep and its homeostatic regulation in mice lacking the adenosine A1 receptor. J Sleep Res 2003; 12:283-290.
165. Hayaishi O, Urade Y. Prostaglandin D2 in sleep-wake regulation: recent progress and perspectives. Neuroscientist 2002; 8:12-15.
166. Pentreath VW, Rees K, Owolabi OA, Philip KA, Doua F. The somnogenic T lymphocyte suppressor prostaglandin D2 is selectively elevated in cerebrospinal fluid of advanced sleeping sickness patients. Trans R Soc Trop Med Hyg 1990; 84:795-799.
167. Borbely AA, Achermann P. Concepts and models of sleep regulation: an overview. J Sleep Res 1992; 1:63-79.
168. Wurts SW, Edgar DM. Circadian and homeostatic control of rapid eye movement (REM) sleep: promotion of REM tendency by the suprachiasmatic nucleus. J Neurosci 2000; 20:4300-4310.
169. Kramer A, Yang FC, Snodgrass P et al. Regulation of daily locomotor activity and sleep by hypothalamic EGF receptor signaling. Science 2001; 294:2511-2515.
170. Cheng MY, Bullock CM, Li C et al. Prokineticin 2 transmits the behavioural circadian rhythm of the suprachiasmatic nucleus. Nature 2002; 417:405-410.
171. Chou TC, Scammell TE, Gooley JJ, Gaus SE, Saper CB, Lu J. Critical role of dorsomedial hypothalamic nucleus in a wide range of behavioral circadian rhythms. J Neurosci 2003; 23:10691-10702.
172. Lu J, Zhang YH, Chou TC et al. Contrasting effects of ibotenate lesions of the paraventricular nucleus and subparaventricular zone on sleep-wake cycle and temperature regulation. J Neurosci 2001; 21:4864-4874.
173. Saper CB, Chou TC, Scammell TE. The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci 2001; 24:726-731.
174. Chou TC, Bjorkum AA, Gaus SE, Lu J, Scammell TE, Saper CB. Afferents to the ventrolateral preoptic nucleus. J Neurosci 2002; 22:977-990.
175. Gallopin T, Fort P, Eggermann E et al. Identification of sleep-promoting neurons in vitro. Nature 2000; 404:992-995.